Cannabis and Insomnia: What the Research Actually Shows
For people who struggle to fall asleep or stay asleep, cannabis can seem like an appealing alternative to conventional sleep medications. Some users report that it helps them fall asleep, but the evidence does not yet show that cannabis is a reliable or well-established treatment for insomnia.
Understanding insomnia
Insomnia involves persistent difficulty falling asleep, staying asleep, or obtaining restorative sleep despite having an adequate opportunity to sleep. It can occur on its own or alongside conditions such as chronic pain, anxiety, depression, cardiovascular disease, medication use, or other sleep disorders. Environmental factors—including noise, light, temperature, irregular schedules, and shift work—can also contribute.
Normal sleep cycles move between non-rapid eye movement (NREM) sleep and rapid eye movement (REM) sleep. NREM sleep has three stages: lighter transitional sleep, stable sleep, and deep slow-wave sleep. The balance and continuity of these stages can be affected by medications, substances, illness, stress, and sleep deprivation.
Why cannabis may affect sleep
Cannabis contains numerous cannabinoids, including delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD), and cannabinol (CBN). These compounds interact with the endocannabinoid system, which is involved in processes such as mood, pain, circadian rhythms, and sleep-wake regulation. The biological connection is plausible, but it does not establish that cannabis is an effective treatment for insomnia.
A 2017 review of cannabis, cannabinoids, and sleep found that THC may reduce the time it takes to fall asleep in the short term. However, the review also described possible drawbacks, including changes in sleep architecture, tolerance with repeated use, and sleep disruption during withdrawal. Effects may differ according to the cannabinoid, dose, timing, route of administration, and the person’s underlying health conditions.
What studies of medical cannabis have found
Some observational studies suggest that people who use medical cannabis report better sleep. These studies can identify associations, but they cannot determine whether cannabis caused the improvement. People may sleep better because cannabis reduces pain, anxiety, or other symptoms—not necessarily because it directly treats insomnia.
For example, a 2015 study of sleep-disturbed medical cannabis users found that participants with current insomnia or longer sleep latency were more likely to report using products with higher CBD concentrations. This was a study of product preferences and self-reported symptoms, not a controlled test of whether CBD improved sleep. It therefore cannot establish an optimal THC-to-CBD ratio or prove that one type of cannabis is more effective than another.
Similarly, a 2018 naturalistic study of medical cannabis flower reported short-term improvements in self-reported insomnia symptoms. The researchers also found suggestive associations between product composition and symptom relief. Because participants selected their own products and treatment was not controlled or blinded, the findings should be viewed as preliminary. They do not demonstrate that CBN, THC, or CBD alone was responsible for the reported changes.
More direct evidence came from a small 2021 randomized crossover trial. In that study, adults with insomnia symptoms received a cannabis-based preparation containing THC, CBD, and CBN or a placebo for short treatment periods. The cannabinoid preparation improved participants’ self-reported sleep quality and insomnia symptoms compared with placebo, but the study was small and brief. Its results cannot establish long-term effectiveness, safety, or whether the findings apply to all cannabis products.
The limits of the evidence
A 2020 systematic review and meta-analysis focused specifically on insomnia disorder identified only five eligible clinical studies involving 219 participants. The review found some favorable short-term results, particularly in non-randomized studies, but emphasized the small number of trials and their methodological limitations. Another systematic review similarly concluded that there was insufficient evidence to support the routine clinical use of cannabinoid therapies for any sleep disorder.
Important unanswered questions remain. Researchers still need to determine which cannabinoids, doses, formulations, and treatment schedules—if any—provide meaningful benefits. Longer studies are also needed to examine tolerance, dependence, daytime impairment, interactions with other medications, and the possibility that stopping regular cannabis use may temporarily worsen sleep.
Where treatment stands
For chronic insomnia, the American Academy of Sleep Medicine recommends cognitive behavioral therapy for insomnia (CBT-I) as the primary treatment. CBT-I addresses behaviors and beliefs that maintain insomnia and has substantially stronger clinical support than cannabis-based treatment.
People considering cannabis for sleep should discuss it with a qualified health professional, particularly if they take sedatives or other prescription medicines, have a history of substance-use problems, are pregnant, or have symptoms of depression, psychosis, or sleep apnea. Loud snoring, gasping during sleep, or severe daytime sleepiness may indicate sleep apnea rather than uncomplicated insomnia.
The current evidence supports a cautious conclusion: cannabis and individual cannabinoids may help some people feel that they sleep better in the short term, but medical cannabis has not been established as a dependable treatment for insomnia. More rigorous, longer-term clinical trials are needed before its benefits and risks can be defined with confidence.
